Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 11 of 668 for:    CARBON DIOXIDE AND arterial

The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02054143
Recruitment Status : Completed
First Posted : February 4, 2014
Last Update Posted : February 4, 2014
Sponsor:
Information provided by (Responsible Party):
Tamas Vegh, MD, University of Debrecen

Brief Summary:

Purpose:

  • The purpose of this study is to examine the effect of different carbon-dioxide concentrations on cerebral CO2 sensitivity and the resistance and stiffness of systemic arteries during anesthesia with sevoflurane. Sevoflurane is a widely and commonly used inhalational anaesthetic, that is mainly used for the maintenance of general anesthesia.
  • Changes in the velocity of cerebral blood flow and arterial stiffness due to the different exhaled carbon-dioxide concentrations will allow us to conclude how sevoflurane affects these parameters during the course of the narcosis.

Instruments:

  • An ultrasound device called transcranial doppler (TCD) is used to measure the velocity of blood flow within a main artery located inside the skull.
  • A tonometry device named SphygmoCor is used to assess the pressure wave proceeding in the radial artery, from which the stiffness of the systemic vessels can be concluded.

Measurements:

- Examinations with the ultrasound and tonometry devices are carried out once before the operation, three times during the intervention, with different exhaled CO2 values and once after the operation is completed.

Hypothesis:

- Sevoflurane alters cerebral carbon-dioxide sensitivity and the stiffness of systemic arteries.


Condition or disease Intervention/treatment Phase
Sevoflurane Anesthesia Procedure: Partial pressure of CO2 at the end of an exhaled breath Drug: Sevoflurane Phase 4

Detailed Description:

Study protocol:

- The study is conducted in four stages: in the first stage, measurements are performed preoperatively in awake patients. Patients are placed in supine position and mean arterial blood pressure (MAP), heart rate, oxygen saturation are measured. The transcranial doppler (TCD) probe is fixed in place by applying a headband to maintain a constant angle of insonation. Mean blood flow velocity (MBFV) and pulsatility index (PI) in the middle cerebral artery (MCA) are obtained. MCA is insonated through the right temporal window by using pulsed 2 megahertz TCD ultrasound probe. Identification of the MCA is confirmed by using standard criteria, at a depth of 45-55 mm. Cerebral CO2 vasoreactivity is calculated as the percentage change in MBFV or PI for mmHg change in end-tidal CO2 (ETCO2).

SphygmoCor is placed on the left radial artery to obtain data about the central aortic blood pressure, augmentation pressure (AP) and augmentation index normalised to a 75 beat per minute heart rate (Alx75). From the derived aortic pulse, calculations can be made, using the area under the systolic and diastolic part of the curve, to determine the heart's ratio of oxygen supply and demand, it is called the subendocardial viability ratio (SEVR).

As part of the premedication each patient receives 7.5 mg midazolam. Anaesthesia is induced using 2 mcg/kg fentanyl followed by 2 mg/kg propofol. Afterwards 0.6mg/kg rocuronium is given for muscle paralysis and subsequently patients were intubated with a suitable intratracheal tube.

After induction of anaesthesia, the patients are placed on a mechanical ventilation system, using a volume-controlled setting with an air and oxygen mixture set to 0.4 fraction of inspired oxygen (FiO2) , the fresh gas flow rate to 2 l/min and sevoflurane is adjusted to reach a constant 1minimal alveolar concentration (MAC) during examination. Anesthesia is maintained with sevoflurane and on demand fentanyl boluses.

Differences in the depth of anesthesia could influence cerebral activity, thereby cerebral metabolism and blood flow. Bispectral index is placed onto every patient in order to assure constant depth of anaesthesia during the intervention.

The second series of TCD and SphygmoCor measurements are performed 20 minutes after the respiratory rate is set to maintain end-tidal CO2 at 40 mmHg in order to allow sufficient time for equilibrium to be reached and the effect of drugs used for the induction of anesthesia to be terminated. Subsequently the examinations are repeated twice again at 35 and 30 mmHg ETCO2. The measurements were carried out 5-5 minutes after adjusting the minute ventilation to reach target ETCO2 values.

Statistical methods:

- Comparisons between the preoperative and three intraoperative stages of the study are made using repeated measures ANOVA with the Bonferroni post hoc correction. The relationship between MBFV, PI and ETCO2 is assessed using linear regression, while the connection between SEVR, pulse and Alx75 is calculated with bivariate correlation.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 24 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: The Effect of Sevoflurane on Cerebral Vasoreactivity Ans Systemic Arteries
Study Start Date : November 2012
Actual Primary Completion Date : April 2013
Actual Study Completion Date : April 2013

Resource links provided by the National Library of Medicine

Drug Information available for: Sevoflurane

Arm Intervention/treatment
Experimental: Sevoflurane
Sevoflurane was administered to all patients at 1 minimal alveolar concentration (MAC) after the intubation occured until the patient was extubated.
Procedure: Partial pressure of CO2 at the end of an exhaled breath
Three previously defined EtCO2 levels (partial pressure of CO2 at the end of an exhaled breath) were adjusted during anesthesia.
Other Name: EtCO2

Drug: Sevoflurane
Sevoflurane was administered to all patients at 1 minimal alveolar concentration (MAC) during the whole operation.
Other Name: Sevorane




Primary Outcome Measures :
  1. Blood flow velocity in the middle cerebral artery [ Time Frame: Changes from baseline in blood flow velocity at the 15th, 20th and 25th minutes of the operation ]
    Systolic, diastolic and mean blood flow velocities are measured with transcranial doppler device.


Secondary Outcome Measures :
  1. Arterial wall stiffness of the radial artery [ Time Frame: Changes from baseline in arterial stiffness at the 15th, 20th and 25th minutes of the operation ]
    The stiffness of the radial artery is assessed. Stiffness rate is concluded from the augmentation pressure and augmentation index, from which both values are provided by the tonometry device.

  2. Changes in the central systolic and diastolic blood pressure [ Time Frame: Changes from baseline in central blood pressure at the 15th, 20th and 25th minutes of the operation ]
    CEntral blood pressure values are measured by means of tonometry device on the radial artery.


Other Outcome Measures:
  1. Changes in subendocardial viability ratio (SEVR) [ Time Frame: Changes form baseline in SEVR at the 15th, 20th and 25th minutes of the operation ]
    From the derived central aortic pulse pressure, calculations can be made, using the area under the systolic and diastolic part of the curve.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Above the age 18
  • American Society of Anesthesiologists (ASA) physical classification I. or II.
  • Patients undergoing elective varicotomy or inguinal hernioplasty in general anesthesia

Exclusion Criteria:

  • Patients with cerebral, cardiac or systemic vascular disorders (hypertension, diabetes)
  • Patients receiving medication that affects the blood vessels (antihypertensive, antidiabetic, antiarrhythmic medications)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02054143


Locations
Layout table for location information
Hungary
University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care
Debrecen, Hungary, 4032
Sponsors and Collaborators
University of Debrecen
Investigators
Layout table for investigator information
Principal Investigator: Csilla Molnár, MD, PhD University of Debrecen Medical and Health Science Center Department of Anesthesiology and Intensive Care 4032-Debrecen, Nagyerdei krt 98. Hungary Tel/fax: +36-52-255-347

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Tamas Vegh, MD, assistant lecturer anesthesiologist and intensive care specialist, University of Debrecen
ClinicalTrials.gov Identifier: NCT02054143     History of Changes
Other Study ID Numbers: 17637-1/2012/EKU
DEOEC RKEB/IKEB:3584-2012 ( Other Identifier: University of Debrecen, RKEB/IKEB )
First Posted: February 4, 2014    Key Record Dates
Last Update Posted: February 4, 2014
Last Verified: February 2014
Keywords provided by Tamas Vegh, MD, University of Debrecen:
sevoflurane
cerebral vasoreactivity
arterial stiffness
Transcranial Doppler
SphygmoCor
Additional relevant MeSH terms:
Layout table for MeSH terms
Sevoflurane
Platelet Aggregation Inhibitors
Anesthetics, Inhalation
Anesthetics, General
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs